|
BioSante reports top-line results from LibiGel PK study for HSDD in postmenopausal wo
BioSante Pharmaceuticals, Inc., today announced successful completion of its principal LibiGel (testosterone gel) pharmacokinetic (PK) study.
More... |
| All times are GMT -7. The time now is 09:06 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021